These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24401017)

  • 1. Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Pain Med; 2014 Aug; 15(8):1282-93. PubMed ID: 24401017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.
    Sun P; Peng X; Sun S; Novick D; Faries DE; Andrews JS; Wohlreich MM; Wu A
    Pain Pract; 2014 Jan; 14(1):22-31. PubMed ID: 23489659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
    Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Am J Health Syst Pharm; 2013 Dec; 70(24):2207-17. PubMed ID: 24296843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
    Sun P; Zhao Y; Zhao Z; Watson P
    Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
    Margolis J; Cao Z; Fowler R; Harnett J; Sanchez RJ; Mardekian J; Silverman SL
    J Med Econ; 2010; 13(4):738-47. PubMed ID: 21091395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
    Kim SC; Landon JE; Lee YC
    Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin.
    Gore M; Sadosky AB; Zlateva G; Clauw DJ
    Pain Pract; 2009; 9(5):363-74. PubMed ID: 19500273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.
    Udall M; Louder A; Suehs BT; Cappelleri JC; Joshi AV; Patel NC
    J Med Econ; 2013; 16(6):784-92. PubMed ID: 23565813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
    Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
    Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
    Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
    Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):32-44. PubMed ID: 21970698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia.
    Gore M; Sadosky A; Zlateva G; Clauw D
    Am J Manag Care; 2010 May; 16(5 Suppl):S144-53. PubMed ID: 20586523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
    Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
    BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.